Director at Prelude Therapeutics (PRLD) receives 38,000 stock options at $3.94 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Prelude Therapeutics Inc director Sandor Victor received a grant of stock options covering 38,000 shares of common stock. The options have an exercise price of $3.94 per share and expire on June 8, 2036.
The award will fully vest upon the earlier of the company’s next annual stockholder meeting or the one-year anniversary of the grant date, as long as Victor continues providing service through the applicable vesting date. After this grant, he holds options for 38,000 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Sandor Victor
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (Right to Buy) | 38,000 | $0.00 | -- |
Holdings After Transaction:
Director Stock Option (Right to Buy) — 38,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 38,000 options
Exercise price: $3.94 per share
Expiration date: June 8, 2036
+2 more
5 metrics
Option grant size
38,000 options
Director stock option grant covering common shares
Exercise price
$3.94 per share
Strike price for director stock options
Expiration date
June 8, 2036
Option term end for director grant
Underlying shares
38,000 shares
Common stock underlying the options
Holdings after transaction
38,000 options
Total options held following this grant
Key Terms
Director Stock Option (Right to Buy), grant, award, or other acquisition, exercise price, expiration date, +1 more
5 terms
Director Stock Option (Right to Buy) financial
"security_title: Director Stock Option (Right to Buy)"
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price of 3.9400 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-08T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
annual stockholder meeting financial
"vest upon the earlier of the Issuer's next annual stockholder meeting"
An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.
FAQ
What did Prelude Therapeutics (PRLD) director Sandor Victor report in this Form 4?
Director Sandor Victor reported receiving a grant of stock options for 38,000 shares of Prelude Therapeutics common stock. These are compensation-related options, not an open-market purchase, and give him the right to buy shares at a preset exercise price.
What is the exercise price of Sandor Victor’s Prelude Therapeutics (PRLD) stock options?
The options have an exercise price of $3.94 per share. This is the fixed price at which he can buy Prelude Therapeutics common stock once the options vest, regardless of the market price at that time.
When do Sandor Victor’s Prelude Therapeutics (PRLD) options vest?
The options will fully vest on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant date. Vesting requires that he continue providing service to Prelude Therapeutics through the applicable vesting date.
When do Sandor Victor’s Prelude Therapeutics (PRLD) stock options expire?
The stock options expire on June 8, 2036. After this expiration date, any unexercised options will lapse and can no longer be used to buy Prelude Therapeutics common stock at the $3.94 per-share exercise price.